COVID-19 Pandemic Boosts Global Vaccine Producers' Net Income

Market

Lite

Yosepha Pusparisa 11/05/2021 14:30 WIB

URL has been copied

Memuat...

The COVID-19 pandemic boosted the net income of several global vaccine companies in Q1 2021. Johnson & Johnson recorded the highest revenue during that period, at US$6.2 billion.

Net Income of Covid-19 Vaccine Companies (Year-over-Year)

A Font Kecil
A Font Sedang
A Font Besar

Access single data

COVID-19 Pandemic Boosts Global Vaccine Producers' Net Income

Want to get more access to Data Stories with a more affordable price? Subscribe.

By subscribing, you join us in presenting quality data.

Get:

Premium Data Stories access
Comfortable reading without ads
Download data in XLS, PDF, and image format
Access to data source information

Basic

~~Rp100.000~~

Rp50.000/month

Professional

~~Rp100.000~~

Rp150.000/month

Institutional For organizations

We accept the following payments:

Some payment methods are still in the process of being activated.

Net Income of Covid-19 Vaccine Companies (Year-over-Year)

Download

Source

A Small Font
A Medium Font
A Bigger Font

The net income of several global vaccine companies increased until the first quarter of 2021. This was driven by the increased demand for vaccines and medical equipment during the Covid-19 coronavirus pandemic.

Johnson & Johnson, for example, earned the highest net income compared to other Covid-19 vaccine producers. The multinational company from New Jersey, United States, recorded US$6.2 billion or Rp 88 trillion (exchange rate Rp 14,200/US$) in the first quarter of 2021, a 7% increase compared to the same period the previous year.

Pfizer recorded US$4.9 billion in the first quarter of 2021. The net income of the company headquartered in New York, US, increased by 45% in January-March 2021 compared to the same period last year.

Meanwhile, Moderna recorded a net income of US$1.2 billion in the first quarter of 2021. The company from Massachusetts, US, successfully rebounded after losing US$124 million in the first quarter of 2020.

Editor : Dimas Jarot Bayu

"Disclosure: This is an AI-generated translation of the original article. We strive for accuracy, but please note that automated translations may contain errors or slight inconsistencies."